Nonpeptide tachykinin receptor antagonists. III. SB 235375, a low central nervous system-penetrant, potent and selective neurokinin-3 receptor antagonist, inhibits citric acid-induced cough and airways hyper-reactivity in guinea pig's

被引:69
作者
Hay, DWP
Giardina, GAM
Griswold, DE
Underwood, DC
Kotzer, CJ
Bush, B
Potts, W
Sandhu, P
Lundberg, D
Foley, JJ
Schmidt, DB
Martin, LD
Kilian, D
Legos, JJ
Barone, FC
Luttmann, MA
Grugni, M
Raveglia, LF
Sarau, HM
机构
[1] GlaxoSmithKline, Dept Pulm Biol, Ctr Excellence Drug Discovery, Resp Inflammat & Resp Pathogens, King Of Prussia, PA 19406 USA
[2] GlaxoSmithKline, Dept Drug Metab & Pharmacokinet, King Of Prussia, PA 19406 USA
[3] GlaxoSmithKline, Dept Cardiovasc Biol, King Of Prussia, PA 19406 USA
[4] Dept Med Chem, Milan, Italy
关键词
D O I
10.1124/jpet.300.1.314
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In this report the in vitro and in vivo pharmacological and pharmacokinetic profile of (-)-(S) -N-(alpha-ethylbenzyl)-3- (carboxymethoxy)-2-phenylquinoline-4-carboxamide (SB 235375), a low central nervous system (CNS)-penetrant, human neurokinin-3 (NK-3) receptor (hNK-3R) antagonist, is described. SB 235375 inhibited I-125-[MePhe(7)]-neurokinin B (NKB) binding to membranes of Chinese hamster ovary (CHO) cells expressing the hNK-3R (CHO-hNK-3R) with a K-i = 2.2 nM and antagonized competitively NKB-Induced Ca2+ mobilization in human embryonic kidney (HEK) 293 cells expressing the hNK-3R (HEK 293-hNK-3R) with a K-b = 12 nM. SB 235375 antagonized senktide (NK-3R)-induced contractions in rabbit isolated iris sphincter (pA(2) = 8.1) and guinea pig ileal circular smooth muscles (pA(2) = 8.3). SB 235375 was selective for the hNK-3R compared with hNK-1 (K-i > 100,000 nM) and hNK-2 receptors (K-i = 209 nM), and was without effect, at 1 muM, in 68 other receptor, enzyme, and ion channel assays. Intravenous SB 235375 produced a dose-related inhibition of miosis induced by i.v. senktide in the rabbit (ED50 of 0.56 mg/kg). Intraperitoneal SB 235375 (10-30 mg/kg) inhibited citric acid-induced cough and airways hyper-reactivity in guinea pigs. In mice oral SB 235375 (3-30 mg/kg) was without significant effect on the behavioral responses induced by intracerebral ventricular administration of senktide. Pharmacokinetic evaluation in the mouse and rat revealed that oral SB 235375 was well absorbed systemically but did not effectively cross the blood-brain barrier. The preclinical profile of SB 235375, encompassing high affinity, selectivity, oral activity, and low CNS penetration, suggests that it is an appropriate tool compound to define the pathophysiological roles of the NK-3Rs in the peripheral nervous system.
引用
收藏
页码:314 / 323
页数:10
相关论文
共 43 条
[1]  
ARENAS E, 1991, J NEUROSCI, V11, P2332
[2]   SOME QUANTITATIVE USES OF DRUG ANTAGONISTS [J].
ARUNLAKSHANA, O ;
SCHILD, HO .
BRITISH JOURNAL OF PHARMACOLOGY AND CHEMOTHERAPY, 1959, 14 (01) :48-58
[3]   MOLECULAR CHARACTERIZATION, EXPRESSION AND LOCALIZATION OF HUMAN NEUROKININ-3 RECEPTOR [J].
BUELL, G ;
SCHULZ, MF ;
ARKINSTALL, SJ ;
MAURY, K ;
MISSOTTEN, M ;
ADAMI, N ;
TALABOT, F ;
KAWASHIMA, E .
FEBS LETTERS, 1992, 299 (01) :90-95
[4]  
CHEN YJ, 1993, J PHARMACOL EXP THER, V267, P1176
[5]  
CHENG YC, 1984, BIOCHEM PHARMACOL, V22, P3099
[6]   A tachykinin NK3 receptor antagonist, SR 142801 (Osanetant), prevents substance P-induced bronchial hyperreactivity in guinea-pigs [J].
Daoui, S ;
Cui, YY ;
Lagente, V ;
Emonds-Alt, X ;
Advenier, C .
PULMONARY PHARMACOLOGY & THERAPEUTICS, 1997, 10 (5-6) :261-270
[7]   Involvement of tachykinin NK3 receptors in citric acid-induced cough and bronchial responses in guinea pigs [J].
Daoui, S ;
Cognon, C ;
Naline, E ;
Emonds-Alt, X ;
Advenier, C .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1998, 158 (01) :42-48
[8]   Neurokinin B- and specific tachykinin NK3 receptor agonists-induced airway hyperresponsiveness in the guinea-pig [J].
Daoui, S ;
Naline, E ;
Lagente, V ;
Emonds-Alt, X ;
Advenier, C .
BRITISH JOURNAL OF PHARMACOLOGY, 2000, 130 (01) :49-56
[9]  
DING YQ, 1996, J COMP NEUROL, V364, P291
[10]   CHARACTERIZATION OF NEUROKININ RECEPTORS IN VARIOUS ISOLATED ORGANS BY THE USE OF SELECTIVE AGONISTS [J].
DION, S ;
DORLEANSJUSTE, P ;
DRAPEAU, G ;
RHALEB, NE ;
ROUISSI, N ;
TOUSIGNANT, C ;
REGOLI, D .
LIFE SCIENCES, 1987, 41 (20) :2269-2278